Article Text

Download PDFPDF
Basic science for the chest physician
Ion channels
  1. Peter Bradding1,
  2. Heike Wulff2
  1. 1Department of Infection, Immunity and Inflammation, Institute for Lung Health, University of Leicester, Leicester, UK
  2. 2Department of Pharmacology, University of California, Davis, California, USA
  1. Correspondence to Professor Peter Bradding, Department of Respiratory Medicine, Glenfield Hospital, Groby Rd, Leicester LE3 9QP, UK; pb46{at}le.ac.uk

Abstract

Effective therapies for the 10% of patients with ‘severe’ asthma remain elusive, while other pulmonary diseases such as idiopathic pulmonary fibrosis are currently untreatable. Many cellular processes rely heavily on signals delivered by changes in the intracellular-free Ca2+ concentration, in many cases relying on Ca2+ influx from the extracellular fluid through specific ion channels. This Ca2+ influx is, to some extent, dependent on the plasma membrane potential, which is controlled by the flow of other ions such as K+ and Cl through their own channels. Irrespective of the point from where pathophysiological cell function is sustained, all mechanisms are predicted to rely heavily on the activity of the final effector ion channels required for pathological cell function. Ion channels are therefore highly attractive targets for the treatment of many diverse diseases, including those affecting the lung.

  • Asthma
  • Cough/Mechanisms/Pharmacology
  • Interstitial Fibrosis

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.